Preparation of Kartogenin-Conjugated Chitosan-Hyaluronic Acid Hydrogel for Nucleus Pulposus Regeneration

被引:0
|
作者
Luo Z.-Q. [1 ]
Wu Z.-S. [1 ]
Tan J. [1 ]
Jiang Y.-L. [1 ]
He X.-X. [1 ]
Zhu Y.-X. [1 ]
机构
[1] Shenzhen Key Laboratory for Anti-ageing and Regenerative Medicine, Health Science Center, Shenzhen University, Shenzhen
关键词
Chitosan; Hyaluronic acid; Hydrogel; Kartogenin; Nucleus pulposus;
D O I
10.3969/j.issn.1003-9015.2018.06.025
中图分类号
学科分类号
摘要
Injectable constructs for in vivo gelation have many advantages in the regeneration of degenerated nucleus pulposus. Injectable hydrogel consisting of chitosan (CS) and hyaluronic acid (HA) crosslinked by glycerol phosphate (GP) (with different CS:GP:HA ratios: 6:3:1,5:3:2,4:3:3,3:3:4, 2:3:5,1:3:6,V:V:V) was developed for kartogenin (KGN) delivery. In vitro gelation time, morphology, swelling ratio, weight loss, compressive modulus, cumulative release of KGN and biocompatibility were studied. Human adipose-derived stem cells (ADSCs) were encapsulated in the hydrogel to study the effects of KGN, TGF-β and KGN+TGF-β on stem cell proliferation and differentiation into nucleus pulposus-like cells. The results show that hydrogel with high HA concentration has shorter gelation time, higher water uptake, faster mass loss and KGN release. KGN-conjugated hydrogel with CS:GP:HA ratio of 5:3:2 show optimal cell proliferation and differentiation. PCR results show significant difference between hydrogel with and without KGN/TGF-β. However, there is no significant difference for nucleus pulposus induced by KGN and/or TGF-β. In conclusion, a KGN conjugated CS-HA hydrogel (5:3:2) for sustained release of KGN is developed for promoting ADSCs proliferation and nucleus pulposus differentiation, which is useful for the repair of degenerative NP tissues after minimally invasive surgery. © 2018, Editorial Board of "Journal of Chemical Engineering of Chinese Universities". All right reserved.
引用
收藏
页码:1427 / 1434
页数:7
相关论文
共 32 条
  • [1] Mern D.S., Beierfuss A., Thome C., Et al., Enhancing human nucleus pulposus cells for biological treatment approaches of degenerative intervertebral disc diseases: a systematic review, Tissue Engineering & Regenerative Medicine, 8, 12, pp. 925-936, (2014)
  • [2] Drazin D., Rosner J., Avalos P., Et al., Stem cell therapy for degenerative disc disease, Advances in Orthopedics, 2012, 11, pp. 1-8, (2012)
  • [3] Oehme D., Goldschlager T., Rosenfeld J.V., Et al., The role of stem cell therapies in degenerative lumbar spine disease: a review, Neurosurgical Review, 38, 3, pp. 429-445, (2015)
  • [4] Sontjen S.H., Nettle D.L., Carnaha M.A., Et al., Biodendrimer-based hydrogel scaffolds for cartilage tissue repair, Biomacromolecules, 7, 1, pp. 310-316, (2006)
  • [5] Tan H., Rubin J.P., Marra K.G., Et al., Injectable in situ forming biodegradable chitosan-hyaluronic acid based hydrogels for adipose tissue regeneration, Organogenesis, 6, 3, pp. 173-180, (2010)
  • [6] Nair M.B., Baranwal G., Vijayan P., Et al., Composite hydrogel of chitosan-poly(hydroxybutyrate-co-valerate) with chondroitin sulfate nanoparticles for nucleus pulposus tissue engineering, Colloids and Surfaces B: Biointerfaces, 136, pp. 84-92, (2015)
  • [7] Singh Y.P., Bhardwaj N., Mandal B.B., Et al., Potential of agarose/silk fibroin blended hydrogel for in vitro cartilage tissue engineering, ACS Applied Materials & Interfaces, 8, 33, pp. 21236-21249, (2016)
  • [8] Atta S., Khaliq S., Islam A., Et al., Injectable biopolymer based hydrogels for drug delivery applications, International Journal of Biological Macromolecules, 80, pp. 240-245, (2015)
  • [9] Ravindran S., Gao Q., Kotecha M., Et al., Biomimetic extracellular matrix-incorporated scaffold induces osteogenic gene expression in human marrow stromal cells, Tissue Engineering Part A, 18, 3-4, pp. 295-309, (2012)
  • [10] Tan H., Ramirez C.M., Miljkovic N., Et al., Thermosensitive injectable hyaluronic acid hydrogel for adipose tissue engineering, Biomaterials, 30, 36, pp. 6844-6853, (2009)